{"id":"https://openalex.org/W4405679151","doi":"https://doi.org/10.30895/2312-7821-2024-12-4-463-476","title":"WoE Analysis and Key Risk Factors in Preclinical Development of Medicinal Products: A Review","display_name":"WoE Analysis and Key Risk Factors in Preclinical Development of Medicinal Products: A Review","publication_year":2024,"publication_date":"2024-11-05","ids":{"openalex":"https://openalex.org/W4405679151","doi":"https://doi.org/10.30895/2312-7821-2024-12-4-463-476"},"language":"en","primary_location":{"id":"doi:10.30895/2312-7821-2024-12-4-463-476","doi":"https://doi.org/10.30895/2312-7821-2024-12-4-463-476","is_oa":true,"landing_page_url":"https://doi.org/10.30895/2312-7821-2024-12-4-463-476","pdf_url":"https://www.risksafety.ru/jour/article/download/463/1282","source":{"id":"https://openalex.org/S4210210648","display_name":"Safety and Risk of Pharmacotherapy","issn_l":"2312-7821","issn":["2312-7821","2619-1164"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Safety and Risk of Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.risksafety.ru/jour/article/download/463/1282","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068915467","display_name":"\u0413. \u041d. \u0415\u043d\u0433\u0430\u043b\u044b\u0447\u0435\u0432\u0430","orcid":"https://orcid.org/0000-0001-5121-0858","observed_orcids":["https://orcid.org/0000-0001-5121-0858"]},"institutions":[{"id":"https://openalex.org/I4405258012","display_name":"Federal State Budgetary Institution \u2018Scientific Centre for Expert Evaluation of Medicinal Products\u2019 of the Ministry of Health of the Russian Federation (SCEEMP)","ror":"https://ror.org/05xze5t06","country_code":"RU","type":"government","lineage":["https://openalex.org/I4210117042","https://openalex.org/I4405258012"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"G. N. Engalycheva","raw_affiliation_strings":["Scientific Centre for Expert Evaluation of Medicinal Products"],"raw_orcid":"https://orcid.org/0000-0001-5121-0858","affiliations":[{"raw_affiliation_string":"Scientific Centre for Expert Evaluation of Medicinal Products","institution_ids":["https://openalex.org/I4405258012"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089638701","display_name":"R. D. Syubaev","orcid":"https://orcid.org/0000-0002-6729-2349","observed_orcids":["https://orcid.org/0000-0002-6729-2349"]},"institutions":[{"id":"https://openalex.org/I4405258012","display_name":"Federal State Budgetary Institution \u2018Scientific Centre for Expert Evaluation of Medicinal Products\u2019 of the Ministry of Health of the Russian Federation (SCEEMP)","ror":"https://ror.org/05xze5t06","country_code":"RU","type":"government","lineage":["https://openalex.org/I4210117042","https://openalex.org/I4405258012"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"R. D. Syubaev","raw_affiliation_strings":["Scientific Centre for Expert Evaluation of Medicinal Products"],"raw_orcid":"https://orcid.org/0000-0002-6729-2349","affiliations":[{"raw_affiliation_string":"Scientific Centre for Expert Evaluation of Medicinal Products","institution_ids":["https://openalex.org/I4405258012"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405258012"],"apc_list":null,"apc_paid":null,"fwci":2.5882,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.8789364,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":97},"biblio":{"volume":"12","issue":"4","first_page":"463","last_page":"476"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.34860000014305115,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.34860000014305115,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.3125,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13165","display_name":"Agricultural safety and regulations","score":0.18299999833106995,"subfield":{"id":"https://openalex.org/subfields/1106","display_name":"Food Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/weight-of-evidence","display_name":"weight of evidence","score":0.9670000076293945},{"id":"https://openalex.org/keywords/preclinical-drug-development","display_name":"preclinical drug development","score":0.7749999761581421},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.6869999766349792},{"id":"https://openalex.org/keywords/immunotoxicity","display_name":"immunotoxicity","score":0.9200000166893005},{"id":"https://openalex.org/keywords/reproductive-toxicity","display_name":"reproductive toxicity","score":0.9980000257492065},{"id":"https://openalex.org/keywords/carcinogenicity","display_name":"carcinogenicity","score":0.9900000095367432},{"id":"https://openalex.org/keywords/pediatric-drug-development","display_name":"pediatric drug development","score":0.734000027179718},{"id":"https://openalex.org/keywords/small-molecules","display_name":"small molecules","score":0.6679999828338623},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ich-guidelines","display_name":"ICH guidelines","score":0.6050000190734863},{"id":"https://openalex.org/keywords/russian-terminology","display_name":"Russian terminology","score":0.4519999921321869},{"id":"https://openalex.org/keywords/data-transparency","display_name":"data transparency","score":0.4959999918937683}],"concepts":[{"id":"https://openalex.org/C26517878","wikidata":"https://www.wikidata.org/wiki/Q228039","display_name":"Key (lock)","level":2,"score":0.673993706703186},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49866747856140137},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.4271894693374634},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36603254079818726},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.32444003224372864},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.1994684636592865},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.04196518659591675}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.30895/2312-7821-2024-12-4-463-476","doi":"https://doi.org/10.30895/2312-7821-2024-12-4-463-476","is_oa":true,"landing_page_url":"https://doi.org/10.30895/2312-7821-2024-12-4-463-476","pdf_url":"https://www.risksafety.ru/jour/article/download/463/1282","source":{"id":"https://openalex.org/S4210210648","display_name":"Safety and Risk of Pharmacotherapy","issn_l":"2312-7821","issn":["2312-7821","2619-1164"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Safety and Risk of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmh:https://cyberleninka.ru/article/n/woe-analiz-i-klyuchevye-faktory-riska-pri-doklinicheskoy-razrabotke-lekarstvennyh-preparatov-obzor","doi":null,"is_oa":false,"landing_page_url":"https://cyberleninka.ru/article/n/woe-analiz-i-klyuchevye-faktory-riska-pri-doklinicheskoy-razrabotke-lekarstvennyh-preparatov-obzor","pdf_url":null,"source":{"id":"https://openalex.org/S4306401404","display_name":"CyberLeninK (CyberLeninka)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"text"},{"id":"pmh:oai:doaj.org/article:9a84c3beba544217982c591ad55b5d8d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/9a84c3beba544217982c591ad55b5d8d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0411\u0435\u0437\u043e\u043f\u0430\u0441\u043d\u043e\u0441\u0442\u044c \u0438 \u0440\u0438\u0441\u043a \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u0438, Vol 12, Iss 4, Pp 463-476 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.30895/2312-7821-2024-12-4-463-476","doi":"https://doi.org/10.30895/2312-7821-2024-12-4-463-476","is_oa":true,"landing_page_url":"https://doi.org/10.30895/2312-7821-2024-12-4-463-476","pdf_url":"https://www.risksafety.ru/jour/article/download/463/1282","source":{"id":"https://openalex.org/S4210210648","display_name":"Safety and Risk of Pharmacotherapy","issn_l":"2312-7821","issn":["2312-7821","2619-1164"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Safety and Risk of Pharmacotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.4000000059604645,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4405679151.pdf","grobid_xml":"https://content.openalex.org/works/W4405679151.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W1879098942","https://openalex.org/W1906935673","https://openalex.org/W2003347321","https://openalex.org/W2193402699","https://openalex.org/W2520642251","https://openalex.org/W2525856467","https://openalex.org/W2890153344","https://openalex.org/W3017834715","https://openalex.org/W4321267074","https://openalex.org/W4386760523","https://openalex.org/W4387310787","https://openalex.org/W4393979130","https://openalex.org/W4394722965","https://openalex.org/W4398255105"],"related_works":["https://openalex.org/W2158831073","https://openalex.org/W2193402699","https://openalex.org/W2047986756","https://openalex.org/W4400154618","https://openalex.org/W4414076331","https://openalex.org/W4394722965","https://openalex.org/W2945450575","https://openalex.org/W4302023734","https://openalex.org/W4398255105","https://openalex.org/W2890153344"],"abstract_inverted_index":{"INTRODUCTION.":[0],"In":[1],"recent":[2],"years,":[3],"the":[4,8,14,36,44,49,54,63,74,124,134,143,148,160,174,182,199,202,212,215,242,266,276],"Russian":[5,50,197],"Federation":[6,51],"and":[7,34,38,73,87,102,120,127,136,147,179,187,193,207,233,251,281,292,308],"Eurasian":[9],"Economic":[10,177],"Union":[11],"have":[12],"included":[13],"concept":[15,126,206],"of":[16,18,56,65,69,80,90,139,145,151,165,244,248,254,260,278],"\u2018weight":[17],"evidence\u2019":[19],"(WoE)":[20],"in":[21,32,43,60,130,142,223,272,275,295],"regulatory":[22,46,88,114,149,309],"documents.":[23,47],"International":[24,161],"regulators":[25],"place":[26],"great":[27],"emphasis":[28],"on":[29,99,123],"data":[30,238],"transparency":[31],"documenting":[33],"assessing":[35],"WoE,":[37],"their":[39,249,305],"position":[40],"is":[41,239],"reflected":[42],"relevant":[45],"However,":[48],"has":[52],"faced":[53],"absence":[55],"consistent":[57],"Russian-language":[58],"terminology":[59],"this":[61,296],"area,":[62],"lack":[64],"a":[66,77,205],"clear":[67],"vision":[68],"WoE":[70,82,100,125,140,203,224,261,289],"assessment":[71,101,128,290],"principles,":[72],"need":[75,267],"for":[76,84,105,163,168,170,176,268,284],"sound":[78],"understanding":[79],"applied":[81],"methods":[83,129],"pharmaceutical":[85],"development":[86,144,277],"review":[89,150],"preclinical":[91,245,270,302],"study":[92,110,152,303],"results.":[93,153],"These":[94],"gaps":[95],"require":[96],"collated":[97],"information":[98],"practical":[103,137],"guidance":[104],"its":[106,209],"use.":[107,286],"AIM.":[108],"This":[109,155,256],"aimed":[111],"to":[112,132,241,264],"analyse":[113],"documents":[115,158,192],"as":[116,118,204],"well":[117],"scientific":[119],"methodological":[121],"publications":[122],"order":[131],"investigate":[133],"opportunities":[135],"applications":[138],"analysis":[141],"medicines":[146],"DISCUSSION.":[154],"article":[156,213,257,297],"covers":[157],"by":[159,301],"Council":[162],"Harmonisation":[164],"Technical":[166],"Requirements":[167],"Pharmaceuticals":[169],"Human":[171],"Use":[172],"(ICH),":[173],"Organisation":[175],"Co-operation":[178],"Development":[180],"(OECD),":[181],"European":[183],"Chemicals":[184],"Agency":[185],"(ECHA),":[186],"other":[188],"organisations.":[189],"Using":[190],"these":[191],"taking":[194],"into":[195],"account":[196],"terminology,":[198],"authors":[200],"clarify":[201],"explain":[208],"assessment.":[210],"Furthermore,":[211],"classifies":[214],"key":[216],"risk":[217],"factors":[218],"that":[219],"must":[220],"be":[221,299],"considered":[222],"analysis,":[225],"with":[226],"examples":[227,259],"drawn":[228],"from":[229],"immunotoxicity,":[230],"reproductive":[231],"toxicity,":[232],"carcinogenicity":[234],"studies.":[235],"Analysing":[236],"such":[237],"critical":[240],"design":[243],"studies,":[246],"interpretation":[247],"results,":[250],"safety":[252],"evaluation":[253],"medicines.":[255,312],"provides":[258],"assessments":[262],"conducted":[263],"consider":[265],"additional":[269],"studies":[271],"juvenile":[273],"animals":[274],"small":[279],"molecules":[280],"monoclonal":[282],"antibodies":[283],"paediatric":[285],"CONCLUSION.":[287],"The":[288],"algorithms":[291],"criteria":[293],"described":[294],"may":[298],"implemented":[300],"initiators,":[304],"research":[306],"teams,":[307],"experts":[310],"evaluating":[311]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2024-12-22T00:00:00"}